Below are the most recent publications written about "Iridium Radioisotopes" by people in Profiles.
-
Peppa V, Thomson RM, Enger SA, Fonseca GP, Lee C, Lucero JNE, Mourtada F, Siebert FA, Vijande J, Papagiannis P. A MC-based anthropomorphic test case for commissioning model-based dose calculation in interstitial breast 192-Ir HDR brachytherapy. Med Phys. 2023 Jul; 50(7):4675-4687.
-
Ma Y, Vijande J, Ballester F, Tedgren ?C, Granero D, Haworth A, Mourtada F, Fonseca GP, Zourari K, Papagiannis P, Rivard MJ, Siebert FA, Sloboda RS, Smith R, Chamberland MJP, Thomson RM, Verhaegen F, Beaulieu L. A generic TG-186 shielded applicator for commissioning model-based dose calculation algorithms for high-dose-rate 192 Ir brachytherapy. Med Phys. 2017 Nov; 44(11):5961-5976.
-
Erickson BA, Bittner NH, Chadha M, Mourtada F, Demanes DJ. The American College of Radiology and the American Brachytherapy Society practice parameter for the performance of radionuclide-based high-dose-rate brachytherapy. Brachytherapy. 2017 Jan - Feb; 16(1):75-84.
-
Ballester F, Carlsson Tedgren ?, Granero D, Haworth A, Mourtada F, Fonseca GP, Zourari K, Papagiannis P, Rivard MJ, Siebert FA, Sloboda RS, Smith RL, Thomson RM, Verhaegen F, Vijande J, Ma Y, Beaulieu L. A generic high-dose rate (192)Ir brachytherapy source for evaluation of model-based dose calculations beyond the TG-43 formalism. Med Phys. 2015 Jun; 42(6):3048-61.
-
Beaulieu L, Carlsson Tedgren A, Carrier JF, Davis SD, Mourtada F, Rivard MJ, Thomson RM, Verhaegen F, Wareing TA, Williamson JF. Report of the Task Group 186 on model-based dose calculation methods in brachytherapy beyond the TG-43 formalism: current status and recommendations for clinical implementation. Med Phys. 2012 Oct; 39(10):6208-36.
-
Mikell JK, Klopp AH, Gonzalez GM, Kisling KD, Price MJ, Berner PA, Eifel PJ, Mourtada F. Impact of heterogeneity-based dose calculation using a deterministic grid-based Boltzmann equation solver for intracavitary brachytherapy. Int J Radiat Oncol Biol Phys. 2012 Jul 01; 83(3):e417-22.
-
Mikell JK, Mourtada F. Dosimetric impact of an 192Ir brachytherapy source cable length modeled using a grid-based Boltzmann transport equation solver. Med Phys. 2010 Sep; 37(9):4733-43.
-
Hill-Kayser CE, Chacko D, Hwang WT, Vapiwala N, Solin LJ. Long-term clinical and cosmetic outcomes after breast conservation treatment for women with early-stage breast carcinoma according to the type of breast boost. Int J Radiat Oncol Biol Phys. 2011 Mar 15; 79(4):1048-54.
-
Price MJ, Kry SF, Eifel PJ, Salehpour M, Mourtada F. Dose perturbation due to the polysulfone cap surrounding a Fletcher-Williamson colpostat. J Appl Clin Med Phys. 2010 Jan 28; 11(1):3146.
-
Price MJ, Gifford KA, Horton JL, Eifel PJ, Gillin MT, Lawyer AA, Mourtada F. Monte Carlo model for a prototype CT-compatible, anatomically adaptive, shielded intracavitary brachytherapy applicator for the treatment of cervical cancer. Med Phys. 2009 Sep; 36(9):4147-55.